Scabies: a ubiquitous neglected skin disease

Lancet Infectious Diseases

Volumn 6, Issue 12, 2006, Pages 769-779

  Hengge, Ulrich R ^a   Currie, Bart J ^b   Jäger, Gerold ^c   Lupi, Omar ^d   Schwartz, Robert A ^e  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c Ikonda Hospital   (Tanzania)

^d FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL BENZOATE; BIOALLETHRIN; CORTICOSTEROID; CROTAMITON; HOUSE DUST ALLERGEN; IVERMECTIN; LINDANE; LIPPIA MULTIFOLIA EXTRACT; MENTHOL; PERMETHRIN; PIMECROLIMUS; PIPERONYL BUTOXIDE; PLANT EXTRACT; PRAMOCAINE; PRAX; STEROID; SULFUR; TEA TREE OIL;

ANOREXIA; APPLICATION SITE BURNING; APPLICATION SITE ERYTHEMA; ARTHRALGIA; ASTHENIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CONJUNCTIVITIS; CONTACT DERMATITIS; CONVULSION; CROSS REACTION; DELAYED HYPERSENSITIVITY; DEVELOPED COUNTRY; DIARRHEA; DRUG MECHANISM; DRUG METABOLISM; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; EPIDEMIC; ERYTHEMA; FEVER; HEADACHE; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; INSOMNIA; IRRITABILITY; IRRITANT DERMATITIS; KIDNEY DISEASE; LIPPIA; LIPPIA MULTIFOLIA; MACULOPAPULAR RASH; MUSCLE SPASM; MYALGIA; NEUROTOXICITY; PRIORITY JOURNAL; PRURITUS; RESTLESSNESS; REVIEW; SARCOPTES SCABIEI; SCABIES; SIDE EFFECT; TH1 CELL; TH2 CELL; VERTIGO; VOMITING; WAR;

ANIMALS; BENZOATES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INSECTICIDES; IVERMECTIN; LINDANE; MALE; PYRETHRINS; SARCOPTES SCABIEI; SCABIES; TOLUIDINES;

EID: 33845435275     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(06)70654-5     Document Type: Review

References (117)

1. Van Hee R. Jeremy Thriverius (1504-1554): humanist doctor, born 500 years ago. Rev Med Brux 26 (2005) 475-478
2. Alexander J. Scabies. Arthropods and human skin (1984), Springer-Verlag, Berlin 227-292
3. Montesu M., and Cottoni F. GC Bonomo and D Cestoni. Discoverers of the parasitic origin of scabies. Am J Dermatopathol 13 (1991) 425-427
4. Holness D., DeKoven J., and Nethercott J. Scabies in chronic health care institutions. Arch Dermatol 128 (1992) 1257-1260
5. Chosidow O. Scabies and pediculosis. Lancet 355 (2000) 819-826
6. Orkin M. Scabies: what's new?. Curr Probl Dermatol 22 (1995) 105-111
7. Heukelbach J., Oliveira F., and Feldmeier H. Ecoparasitoses and public health in Brazil: challenges for control. Cad Saude Publica 19 (2003) 1535-1540
8. Burgess I. Sarcoptes scabiei and scabies. Adv Parasitol 33 (1994) 235-292
9. Mellanby K. The development of symptoms, parasitic infection and immunity in human scabies. Parasitology 35 (1944) 197-206
10. Sterling G., Janniger C., Kihiczak G., Schwartz R., and Fox M. Scabies. Am Fam Physician 46 (1992) 1237-1241
11. Haag M., Brozena S., and Fenske N. Attack of the scabies: what to do when an outbreak occurs. Geriatrics 48 (1993) 45-46 51-53
12. Pence D., and Ueckermann E. 2002. Sarcoptic mange in wildlife. Rev Sci Tech 21 (2002) 385-398
13. Walton S., Dougall A., Pizzutto S., et al. Genetic epidemiology of Sarcoptes scabiei (Acari: Sarcoptidae) in northern Australia. Int J Parasitol 34 (2004) 839-849
14. Cargill C., Pointon A., Davies P., and Garcia R. Using slaughter inspections to evaluate sarcoptic mange infestation of finishing swine. Vet Parasitol 70 (1997) 191-200
15. Mitra M., Mahanta S., Sen S., Ghosh C., and Hati A. Transmission of Sarcoptes scabiei from animal to man and its control. J Indian Med Assoc 93 (1995) 142-143
16. Menzano A., Rambozzi L., and Rossi L. Outbreak of scabies in human beings, acquired from chamois (Rupicapra rupicapra). Vet Rec 155 (2004) 568
17. Walton S., Choy J., Bonson A., et al. Genetically distinct dog-derived and human-derived Sarcoptes scabiei in scabies-endemic communities in northern Australia. Am J Trop Med Hyg 61 (1999) 542-547
18. Fischer K., Holt D., Harumal P., Currie B., Walton S., and Kemp D. Generation and characterization of cDNA clones from Sarcoptes scabiei var hominis for an expressed sequence tag library: identification of homologues of house dust mite allergens. Am J Trop Med Hyg 68 (2003) 61-64
19. Stewart G., Ward L., Simpson R., and Thompson P. The group III allergen from the house dust mite Dermatophagoides pteronyssinus is a trypsin-like enzyme. Immunology 75 (1992) 29-35
20. Sun G., Stacey M., Schmidt M., Mori L., and Mattoli S. Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J Immunol 167 (2001) 1014-1021
21. Savin J. Scabies in Edinburgh from 1815 to 2000. J R Soc Med 98 (2005) 124-129
22. Christophersen J. The epidemiology of scabies in Denmark, 1900 to 1975. Arch Dermatol 114 (1978) 747-750
23. Burkhart C. Scabies: an epidemiologic reassessment. Ann Intern Med 98 (1983) 498-503
24. Mimouni D., Ankol O., Davidovitch N., Gdalevich M., Zangvil E., and Grotto I. Seasonality trends of scabies in a young adult population: a 20-year follow-up. Br J Dermatol 149 (2003) 157-159
25. Pannell R., Fleming D., and Cross K. The incidence of molluscum contagiosum, scabies and lichen planus. Epidemiol Infect 133 (2005) 985-991
26. Currie B., Connors C., and Krause V. Scabies programs in aboriginal communities. Med J Aust 161 (1994) 636-637
27. Nair B., Joseph A., and Kandamuthan M. Epidemic scabies. Indian J Med Res 65 (1977) 513-518
28. Sachdev T., Gulati P., and Prasad P. A study on prevalence of scabies in a resettlement colony (slum area) and its association with some sociocultural and environmental factors. J Indian Assoc Commun Dis 5 (1982) 88-91
29. Fain A. Epidemiological problems of scabies. Int J Dermatol 17 (1978) 20-30
30. Taplin D., Porcelain S., Meinking T., et al. Community control of scabies: a model based on use of permethrin cream. Lancet 337 (1991) 1016-1018
31. Walton S., McBroom J., Mathews J., Kemp D., and Currie B. Crusted scabies: a molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis 29 (1999) 1226-1230
32. Badiaga S., Menard A., Tissot Dupont H., et al. Prevalence of skin infections in sheltered homeless. Eur J Dermatol 15 (2005) 382-386
33. Tsutsumi M., Nishiura H., and Kobayashi T. Dementia-specific risks of scabies: retrospective epidemiologic analysis of an unveiled nosocomial outbreak in Japan from 1989-90. BMC Infect Dis 5 (2005) 85
34. Shahab R., and Loo D. Bullous scabies. J Am Acad Dermatol 49 (2003) 346-350
35. Veraldi S., Scarabelli G., Zerboni R., Pelosi A., and Gianotti R. Bullous scabies. Acta Derm Venereol 76 (1996) 167-168
36. McKoy R., Moshella S., Orkin M., et al. Parasitic infections and infestations. In: Orkin M., Maibach H., and Dahl M. (Eds). Dermatology (1991), Appleton & Lange, East Norwalk, Connecticut 189-214
37. Almeida Jr. H. Treatment of steroid-resistant nodular scabies with topical pimecrolimus. J Am Acad Dermatol 53 (2005) 357-358
38. Sweitzer S., and Winer L. Norwegian scabies. Arch Derm Syphilol 43 (1941) 678-681
39. Adedayo O., Grell G., and Bellot P. Hospital admissions for human T-cell lymphotropic virus type-1 (HTLV-1) associated diseases in Dominica. Postgrad Med J 79 (2003) 341-344
40. Glover A., Young L., and Goltz A. Norwegian scabies in acquired immunodeficiency syndrome: report of a case resulting in death from associated sepsis. J Am Acad Dermatol 16 (1987) 396-399
41. Kolar K., and Rapini R. Crusted (Norwegian) scabies. Am Fam Physician 44 (1991) 1317-1321
42. Blas M., Bravo F., Castillo W., et al. Norwegian scabies in Peru: the impact of human T cell lymphotropic virus type I infection. Am J Trop Med Hyg 72 (2005) 855-857
43. Roberts L., Huffam S., Walton S., and Currie B. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 50 (2005) 375-381
44. O'Donnell B., O'Loughlin S., and Powell F. Management of crusted scabies. Int J Dermatol 29 (1990) 258-266
45. Estes S., and Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 12 (1993) 26-33
46. Currie B., Huffam S., O'Brien D., and Walton S. Ivermectin for scabies. Lancet 350 (1997) 1551
47. Estes S., and Estes J. Scabies research: another dimension. Semin Dermatol 12 (1993) 34-38
48. Cabrera R., Agar A., and Dahl M. The immunology of scabies. Semin Dermatol 12 (1993) 15-21
49. Falk E., Dale S., Bolle R., and Haneberg B. Antigens common to scabies and house dust mites. Allergy 36 (1981) 233-238
50. Arlian L., Vyszenski-Moher D., Ahmed S., and Estes S. Cross-antigenicity between the scabies mite, Sarcoptes scabiei, and the house dust mite, Dermatophagoides pteronyssinus. J Invest Dermatol 96 (1991) 349-354
51. Arlian L., Rapp C., and Morgan M. Resistance and immune response in scabies-infested hosts immunized with Dermatophagoides mites. Am J Trop Med Hyg 52 (1995) 539-545
52. Arlian L., Morgan M., Estes S., Walton S., Kemp D., and Currie B. Circulating IgE in patients with ordinary and crusted scabies. J Med Entomol 41 (2004) 74-77
53. Falk E., and Bolle R. IgE antibodies to house dust mite in patients with scabies. Br J Dermatol 103 (1980) 283-288
54. Dougall A., Holt D., Fischer K., Currie B., Kemp D., and Walton S. Identification and characterization of Sarcoptes scabiei and Dermatophagoides pteronyssinus glutathione S-transferases: implication as a potential major allergen in crusted scabies. Am J Trop Med Hyg 73 (2005) 977-984
55. Holt D., Fischer K., Allen G., et al. Mechanisms for a novel immune evasion strategy in the scabies mite Sarcoptes scabiei: a multigene family of inactivated serine proteases. J Invest Dermatol 121 (2003) 1419-1424
56. Woodley D., and Saurat J. The burrow ink test and the scabies mite. J Am Acad Dermatol 4 (1981) 715-722
57. Micali G., Lacarrubba F., and Lo Guzzo G. Scraping versus videodermatoscopy for the diagnosis of scabies: a comparative study. Acta Derm Venereol 79 (1999) 396
58. van der Heijden H., Rambags P., Elbers A., van Maanen C., and Hunneman W. Validation of ELISAs for the detection of antibodies to Sarcoptes scabiei in pigs. Vet Parasitol 89 (2000) 95-107
59. Stibich A., and Schwartz R. Papular urticaria. Cutis 68 (2001) 89-91
60. Bowen R. Insects and allergic problems. South Med J 44 (1951) 836-841
61. Steen C., Carbonaro P., and Schwartz R. Arthropods in dermatology. J Am Acad Dermatol 50 (2004) 819-842
62. Georghiou G. Overview of insecticide resistance. In: Green M., Le Baron H., and Moberg W. (Eds). Managing resistance to agrochemicals 421 (1990), American Chemical Society, Washington DC 18-41
63. Tomalik-Scharte D., Lazar A., Meins J., et al. Dermal absorption of permethrin following topical administration. Eur J Clin Pharmacol 61 (2005) 399-404
64. Walker G., and Johnstone P. Interventions for treating scabies. Cochrane Database Syst Rev 3 (2006) CD000320
65. Coleman C., Gillespie E., and White C. Probable topical permethrin-induced neck dystonia. Pharmacotherapy 25 (2005) 448-450
66. Glaziou P., Cartel J., Alzieu P., Briot C., Moulia-Pelat J., and Martin P. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 44 (1993) 331-332
67. Currie B., Harumal P., McKinnon M., and Walton S. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 39 (2004) e8-e12
68. Walton S., Myerscough M., and Currie B. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var hominis. Trans R Soc Trop Med Hyg 94 (2000) 92-96
69. Taplin D., Meinking T., Chen J., and Sanchez R. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 7 (1990) 67-73
70. del Giudice P., and Marty P. Ivermectin: a new therapeutic weapon in dermatology?. Arch Dermatol 135 (1999) 705-706
71. Dourmishev A., Dourmishev L., and Schwartz R. Ivermectin: pharmacology and application in dermatology. Int J Dermatol 44 (2005) 981-988
72. Dent J., Davis M., and Avery L. avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J 16 (1997) 5867-5879
73. Dourmishev A., Serafimova D., Dourmishev L., Mualla M., Papaharalambous V., and Malchevsky T. Crusted scabies of the scalp in dermatomyositis patients: three cases treated with oral ivermectin. Int J Dermatol 37 (1998) 231-234
74. Leppard B., and Naburi A. The use of ivermectin in controlling an outbreak of scabies in a prison. Br J Dermatol 143 (2000) 520-523
75. Meinking T., Taplin D., Hermida J., Pardo R., and Kerdel F. The treatment of scabies with ivermectin. N Engl J Med 333 (1995) 26-30
76. Chouela E., Abeldano A., Pellerano G., et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 135 (1999) 651-655
77. Usha V., and Gopalakrishnan Nair T. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 42 (2000) 236-240
78. Marty P., Gari-Toussaint M., Le Fichoux Y., and Gaxotte P. Efficacy of ivermectin in the treatment of an epidemic of sarcoptic scabies. Ann Trop Med Parasitol 88 (1994) 453
79. Sullivan J., Watt G., and Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Australas J Dermatol 38 (1997) 137-140
80. Paasch U., and Haustein U. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol 39 (2000) 463-470
81. Aubin F., and Humbert P. Ivermectin for crusted (Norwegian) scabies. N Engl J Med 332 (1995) 612
82. Corbett E., Crossley I., Holton J., Levell N., Miller R., and De Cock K. Crusted ("Norwegian") scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genitourin Med 72 (1996) 115-117
83. Huffam S., and Currie B. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis 2 (1998) 152-154
84. Jaramillo-Ayerbe F., and Berrio-Munoz J. Ivermectin for crusted Norwegian scabies induced by use of topical steroids. Arch Dermatol 134 (1998) 143-145
85. Patel A., Hogan P., and Walder B. Crusted scabies in two immunocompromised children: successful treatment with oral ivermectin. Australas J Dermatol 40 (1999) 37-40
86. Dourmishev A., Serafimova D., and Dourmishev L. Efficacy and tolerance of oral ivermectin in scabies. J Eur Acad Dermatol Venereol 11 (1998) 247-251
87. Pacque M., Munoz B., Greene B., White A., Dukuly Z., and Taylor H. Safety of and compliance with community-based ivermectin therapy. Lancet 335 (1990) 1377-1380
88. Gardon J., Gardon-Wendel N., Demanga-Ngangue, Kamgno J., Chippaux J., and Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350 (1997) 18-22
89. Barkwell R., and Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 349 (1997) 1144-1145
90. Coskey R. Scabies: resistance to treatment with crotamiton. Arch Dermatol 115 (1979) 109
91. Hernandez-Perez E. Resistance to antiscabietic drugs. J Am Acad Dermatol 8 (1983) 121-123
92. Witkowski J., and Parish L. Lindane-resistant scabies. J Am Acad Dermatol 27 (1992) 648
93. Boix V., Sanchez-Paya J., Portilla J., and Merino E. Nosocomial outbreak of scabies clinically resistant to lindane. Infect Control Hosp Epidemiol 18 (1997) 677
94. Davies J., Dedhia H., Morgade C., Barquet A., and Maibach H. Lindane poisonings. Arch Dermatol 119 (1983) 142-144
95. Walton S., McKinnon M., Pizzutto S., Dougall A., Williams E., and Currie B. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of Sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol 140 (2004) 563-566
96. Carson C., Hammer K., and Riley T. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 19 (2006) 50-62
97. Oladimeji F., Orafidiya O., Ogunniyi T., and Adewunmi T. Pediculocidal and scabicidal properties of Lippia multiflora essential oil. J Ethnopharmacol 72 (2000) 305-311
98. Tarigan S., and Huntley J. Failure to protect goats following vaccination with soluble proteins of Sarcoptes scabiei: evidence for a role for IgE antibody in protection. Vet Parasitol 133 (2005) 101-109
99. Pettersson E., Ljunggren E., Morrison D., and Mattsson J. Functional analysis and localisation of a delta-class glutathione S-transferase from Sarcoptes scabiei. Int J Parasitol 35 (2005) 39-48
100. McCarthy J., Kemp D., Walton S., and Currie B. Scabies: more than just an irritation. Postgrad Med J 80 (2004) 382-387
101. Lawrence G., Leafasia J., Sheridan J., et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ 83 (2005) 34-42
102. Heukelbach J., van Haeff E., Rump B., Wilcke T., Moura R., and Feldmeier H. Parasitic skin diseases: health care-seeking in a slum in north-east Brazil. Trop Med Int Health 8 (2003) 368-373
103. Wilcke T., Heukelbach J., Saboia-Moura R., and Feldmeier H. Scabies, pediculosis, tungiasis and cutaneous larva migrans in a poor community in northeast Brazil. Acta Tropica 83 suppl 1 (2002) S100
104. Heukelbach J., Winter B., Wilcke T., et al. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ 82 (2004) 563-571
105. Currie B., and Carapetis J. Skin infections and infestations in Aboriginal communities in northern Australia. Australas J Dermatol 41 (2000) 139-143
106. Svartman M., Finklea J., Earle D., Potter E., and Poon-King T. Epidemic scabies and acute glomerulonephritis in Trinidad. Lancet 1 (1972) 249-251
107. Leekassa R., Bizuneh E., Alem A., Fekadu A., and Shibre T. Community diagnosis of common skin diseases in the Zay community of the Zeway Islands, Ethiopia. Ethiop Med J 43 (2005) 189-195
108. Ogunbiyi A., Owoaje E., and Ndahi A. Prevalence of skin disorders in school children in Ibadan, Nigeria. Pediatr Dermatol 22 (2005) 6-10
109. Landwehr D., Keita S., Ponnighaus J., and Tounkara C. Epidemiologic aspects of scabies in Mali, Malawi, and Cambodia. Int J Dermatol 37 (1998) 588-590
110. Henderson C. Skin disease in rural Tanzania. Int J Dermatol 35 (1996) 640-642
111. Birrell G., and Birrell K. Assessment of a 1-year teaching programme in Zanzibar, Tanzania. Lancet 356 (2000) 1084
112. Terry B., Kanjah F., Sahr F., Kortequee S., Dukulay I., and Gbakima A. Sarcoptes scabiei infestation among children in a displacement camp in Sierra Leone. Public Health 115 (2001) 208-211
113. Adjei O., and Brenya R. Secondary bacterial infection in Ghanaian patients with scabies. East Afr Med J 74 (1997) 729-731
114. Henderson C., and Nykia M. Treatment of scabies in rural east Africa: a comparative study of two regimens. Trop Doct 22 (1992) 165-167
115. Wong L., Amega B., Barker R., et al. Factors supporting sustainability of a community-based scabies control program. Australas J Dermatol 43 (2002) 274-277
116. Antony R. Control of scabies (pilot study). Indian J Public Health 26 (1982) 108-111
117. Reid H., and Thorne C. Scabies infestation: the effect of intervention by public health education. Epidemiol Infect 105 (1990) 595-602